Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (7)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
Background BZP-party pills are yet another 'designer drug' which mimics the stimulant qualities of amphetamines and MDMA/Ecstasy. As legal markets for the substance have developed in the last decade (especially amongst young people) so has publi[...]
Article : Périodique
ENGLISH : Methamphetamine use has risen in many countries around the world in recent years, and New Zealand is no exception, with the substance having become well-established in the illicit drug market. While there is much published on the ind[...]Article : Périodique
ENGLISH : In this Harm Reduction Digest Sheridan, Butler, Wilkins and Russell address the emergent phenomenon of so-called 'legal party pills' which have become a significant drug issue in New Zealand and elsewhere. Although banned in a number[...]Article : Périodique
J. SHERIDAN ; C. Y. DONG ; R. BUTLER ; J. BARNES |Background: The last decade has seen the emergence of a new phenomenon in recreational substance use with the availability of herbal and synthetic, unregulated, psychoactive drugs in the market place; alongside this, international concern has de[...]Article : Périodique
BACKGROUND: The legislation on psychoactive substances has a role to play with regard to shaping social values and influencing the normalisation of drug use. In New Zealand from 2005 to 2008, benzylpiperazine-containing 'legal' party pills (BZP-[...]Périodique
ENGLISH : The families of drug users are often overlooked in the planning and delivery of services. This paper is based on interviews with parents of heroin users and staff from a support agency that worked with families affected by drug use. [...]
Article : Périodique
G. CHRISTIE ; R. MARSH ; J. SHERIDAN ; A. WHEELER ; T. SUAALII-SAUNI ; S. BLACK ; R. BUTLER |AIMS: To describe the development and evaluation of the Substances and Choices Scale (SACS), an adolescent alcohol and other drug (AOD) self-report instrument designed in a similar format to the Strengths and Difficulties Questionnaire (SDQ). [...]
